AU2020380256A1 - High salt load conditioning during cation exchange chromatography to remove product-realated impurities - Google Patents
High salt load conditioning during cation exchange chromatography to remove product-realated impurities Download PDFInfo
- Publication number
- AU2020380256A1 AU2020380256A1 AU2020380256A AU2020380256A AU2020380256A1 AU 2020380256 A1 AU2020380256 A1 AU 2020380256A1 AU 2020380256 A AU2020380256 A AU 2020380256A AU 2020380256 A AU2020380256 A AU 2020380256A AU 2020380256 A1 AU2020380256 A1 AU 2020380256A1
- Authority
- AU
- Australia
- Prior art keywords
- sodium chloride
- buffer comprises
- acetate
- cation exchange
- wash buffer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962931863P | 2019-11-07 | 2019-11-07 | |
| US62/931,863 | 2019-11-07 | ||
| PCT/US2020/058772 WO2021091932A1 (en) | 2019-11-07 | 2020-11-04 | High salt load conditioning during cation exchange chromatography to remove product-realated impurities |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2020380256A1 true AU2020380256A1 (en) | 2022-06-09 |
Family
ID=73598211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2020380256A Pending AU2020380256A1 (en) | 2019-11-07 | 2020-11-04 | High salt load conditioning during cation exchange chromatography to remove product-realated impurities |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220372070A1 (https=) |
| EP (1) | EP4055041A1 (https=) |
| JP (2) | JP7760500B2 (https=) |
| KR (1) | KR20220092969A (https=) |
| CN (1) | CN114746441A (https=) |
| AU (1) | AU2020380256A1 (https=) |
| BR (1) | BR112022008649A2 (https=) |
| CA (1) | CA3160143A1 (https=) |
| CL (3) | CL2022001168A1 (https=) |
| IL (1) | IL292594A (https=) |
| MX (1) | MX2022005593A (https=) |
| WO (1) | WO2021091932A1 (https=) |
| ZA (1) | ZA202205010B (https=) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001019970A2 (en) * | 1999-09-15 | 2001-03-22 | Eli Lilly And Company | Chymotrypsin-free trypsin |
| CA2645739A1 (en) * | 2006-03-20 | 2007-09-27 | Medarex, Inc. | Protein purification |
| EP2009101B1 (en) * | 2006-03-31 | 2017-10-25 | Chugai Seiyaku Kabushiki Kaisha | Antibody modification method for purifying bispecific antibody |
| CN104628846B (zh) * | 2013-11-06 | 2019-12-06 | 三生国健药业（上海）股份有限公司 | 重组蛋白质的纯化方法 |
| US9611325B2 (en) * | 2014-07-21 | 2017-04-04 | Wuhan Yzy Biopharma Co., Ltd. | Construction and application of bispecific antibody HER2xCD3 |
| EP3204415B1 (en) * | 2014-10-09 | 2020-06-17 | EngMab Sàrl | Bispecific antibodies against cd3epsilon and ror1 |
| JP6699085B2 (ja) * | 2015-03-25 | 2020-05-27 | 東ソー株式会社 | Ｆｃ結合性タンパク質の精製方法 |
| CN119161488A (zh) * | 2017-11-01 | 2024-12-20 | 中外制药株式会社 | 具有降低的生物活性的抗体变体和同种型 |
| CN110305217B (zh) * | 2018-03-27 | 2022-03-29 | 广州爱思迈生物医药科技有限公司 | 双特异性抗体及其应用 |
-
2020
- 2020-11-04 IL IL292594A patent/IL292594A/en unknown
- 2020-11-04 JP JP2022525306A patent/JP7760500B2/ja active Active
- 2020-11-04 BR BR112022008649A patent/BR112022008649A2/pt not_active Application Discontinuation
- 2020-11-04 EP EP20812494.1A patent/EP4055041A1/en active Pending
- 2020-11-04 AU AU2020380256A patent/AU2020380256A1/en active Pending
- 2020-11-04 KR KR1020227018937A patent/KR20220092969A/ko active Pending
- 2020-11-04 CA CA3160143A patent/CA3160143A1/en active Pending
- 2020-11-04 WO PCT/US2020/058772 patent/WO2021091932A1/en not_active Ceased
- 2020-11-04 US US17/773,886 patent/US20220372070A1/en active Pending
- 2020-11-04 MX MX2022005593A patent/MX2022005593A/es unknown
- 2020-11-04 CN CN202080077935.3A patent/CN114746441A/zh active Pending
-
2022
- 2022-05-04 CL CL2022001168A patent/CL2022001168A1/es unknown
- 2022-05-06 ZA ZA2022/05010A patent/ZA202205010B/en unknown
-
2024
- 2024-06-14 CL CL2024001788A patent/CL2024001788A1/es unknown
-
2025
- 2025-10-14 JP JP2025172458A patent/JP2026012744A/ja active Pending
- 2025-11-26 CL CL2025003712A patent/CL2025003712A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CL2022001168A1 (es) | 2023-01-27 |
| EP4055041A1 (en) | 2022-09-14 |
| MX2022005593A (es) | 2022-06-09 |
| WO2021091932A1 (en) | 2021-05-14 |
| CL2024001788A1 (es) | 2024-09-27 |
| JP2022554282A (ja) | 2022-12-28 |
| CL2025003712A1 (es) | 2026-01-09 |
| IL292594A (en) | 2022-07-01 |
| KR20220092969A (ko) | 2022-07-04 |
| JP7760500B2 (ja) | 2025-10-27 |
| CN114746441A (zh) | 2022-07-12 |
| BR112022008649A2 (pt) | 2022-07-19 |
| CA3160143A1 (en) | 2021-05-14 |
| US20220372070A1 (en) | 2022-11-24 |
| ZA202205010B (en) | 2023-01-25 |
| JP2026012744A (ja) | 2026-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022523025A (ja) | 原薬及び製剤プロセスの統合による生物製剤製造のための連続的な製造プロセス | |
| WO2022072291A1 (en) | Cation exchange chromatography process | |
| US20230058276A1 (en) | Methods for harvesting biomolecules | |
| JP2026048656A (ja) | 生成物関連不純物を除去するためのカチオン交換クロマトグラフィー中の高塩分洗浄 | |
| US20240174752A1 (en) | Modulating product quality of asymmetric multispecific antibodies through the use of temperature | |
| US20260070943A1 (en) | A method for harvesting products from high cell density perfusion cell cultures | |
| JP7760500B2 (ja) | 生成物関連不純物を除去するためのカチオン交換クロマトグラフィー中の高塩分負荷コンディショニング | |
| CN120882878A (zh) | 制备重组il-12白蛋白结合结构域融合蛋白的方法 | |
| EA047099B1 (ru) | Кондиционирование с высокой солевой нагрузкой в ходе катионообменной хроматографии для удаления связанных с продуктом примесей | |
| EA046702B1 (ru) | Способы очистки биспецифических антител при помощи катионообменной хроматографии с использованием промывки с высоким содержанием соли | |
| HK40070045A (en) | High salt load conditioning during cation exchange chromatography to remove product-realated impurities | |
| HK40070589A (en) | High salt washes during cation exchange chromatography to remove product-realated impurities | |
| WO2025251034A1 (en) | Purification method | |
| JP2026505293A (ja) | 細胞培養法 |